Swalqol in Primary Hyperparathyroidism

Completed

• Conditions: Hyperparathyroidism
• Interventions: Procedure: parathyroidectomy

• Registration Number: NCT03968510
• Lead Sponsor: Uşak University

Brief Summary

Swallow related quality of life before and after parathyroidectomy will be evaluated in patients with primary hyperparathyridism.

Detailed Description

Patients who will undergone parathyroidectomy for primary hyperparathyroidism will be included in the study. Swal-Qol and Sf-36 forms will be used for evaluation of quality of life before and 1 month after the surgery. The change in the quality of life and swallowing related quality of life will be evaluated.

Study Timeline

• Study Start: 2018-11-01
• Study First Submitted: 2019-03-20
• Study First Submitted QC: 2019-05-27
• Study First Posted: 2019-05-30
• Primary Completion: 2020-07-01
• Study Completion: 2020-11-01
• Status Verified: 2021-06
• Last Update Submitted: 2021-06-01
• Last Update Posted: 2021-06-04

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 150

Inclusion Criteria

• no diagnosis of Alzheimers disease
• must be able to swallow tablets Planned operation for primary hyperparathyroidism

Exclusion Criteria

• secondary or tertiary hyperparathyroidism
• insulin dependent diabetes
• thyroid disease

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
parathyroidectomy cases	parathyroidectomy	patients who will be operated for primary hyperparathyroidism

Primary Outcome Measures

Name	Time	Method
Change in quality of life	6 months	Quality of life will be evaluated using short form 36

Trial Locations

Locations (1)

Uşak University; 🇹🇷 Uşak, Turkey